Home›People›Ingo Chakravarty
IC

Ingo Chakravarty

Director at Inflammatix, Inc.

DirectorRoles at 3 startups
Updated Nov 19, 2026·Latest SEC filing Nov 19, 2026·Suggest an edit

About Ingo Chakravarty

Ingo Chakravarty is a director of Inflammatix, Inc.

Experience

This experience comes from Ingo Chakravarty's profile and from SEC filings. For roles taken from filings, the years are when the filings name Ingo Chakravarty in the role, so the role may have started earlier or lasted longer.

Inflammatix, Inc. Current
Operating Partner at Northpond Ventures and director
2026 – Present · Sunnyvale, CA
Inflammatix helps emergency teams identify infection type and illness severity from the body's immune response.
SSI Diagnostica Current
Member Board of Directors
2023 – Present
SpeeDx Pty Ltd Current
Chairman of the Board
2023 – Present
Northpond Ventures
Operating Partner
2023 – 2025
Scipher Medicine Corp
Director
2024 · Waltham, MA
Develops tests to help providers select treatments for patients with autoimmune diseases.
SeLux Diagnostics, Inc.
Director
2024 · Charlestown, MA
Antibiotic susceptibility testing systems that help physicians select treatments for infections.
Thermo Fisher Scientific
President & CEO Mesa Biotech, acquired by Thermo Fisher Scientific
2021 – 2023
Mesa Biotech, Inc
President & CEO
2020 – 2021
University of California, San Diego - Jacobs School of Engineering
Graduate Student Mentor
2020
Navican, an Intermountain Health Company
President & CEO
2016 – 2019
GenMark Diagnostics
SVP & GM, International
2013 – 2016
Gen-Probe
VP & GM, Women’s Health
2011 – 2012
Roche Diagnostics
VP Sales TDx, Europe
2008 – 2011
Ventana Medical Systems
Variety of Leadership roles in the US
1996 – 2008
Microm Laborgeraete
Sales Manager
1990 – 1996

Key Colleagues at Startups

The people Ingo Chakravarty works with at each company, as listed on that company's latest Form D.

Inflammatix, Inc. · Form D, Nov 19, 2026
Timothy Sweeney
Timothy Sweeney
Co-Founder and CEO, director
FK
Florian Kainzinger
Founder, Think.Health Ventures and director
Steven Tablak
Steven Tablak
Former Chairman and CEO, GeneWeave
JR
Jonathan Romanowsky
Co-Founder and director
David Persing
David Persing
EVP/Chief Medical Officer, Cepheid and director
Scipher Medicine Corp · Form D, Jul 30, 2024
JL
Joseph Loscalzo
Founder and director
RS
Reginald Seeto
President & Chief Executive Officer, director
SK
Samir Kaul
Founding Partner and Managing Director, Khosla Ventures
GM
Glenn Muir
Director
AB
Albert-Laszlo Barabasi
Founder and director
TS
Todd Sone
Director
TA
Tim Anderson
Director
MK
Miklos Kobor
Director
SeLux Diagnostics, Inc. · Form D, Feb 13, 2024
MH
Michele Healy
Executive officer
JC
Jamie Condie
Director
OG
JW
John Wilson
Chief Commercial Officer
ES
Eric Stern
Executive officer and director
SL
Steven Lufkin
Chief Executive Officer and director
JC
ES
AS
Adam Steel
Executive officer
AV
Aleksandar Vacic
Executive officer

Sources

  1. SECInflammatix, Inc. Form D, filed Nov 19, 2026
  2. SECScipher Medicine Corp Form D, filed Jul 30, 2024
  3. SECSeLux Diagnostics, Inc. Form D, filed Feb 13, 2024